- Open Access
Human Coronavirus NL63 Open Reading Frame 3 encodes a virion-incorporated N-glycosylated membrane protein
© Müller et al; licensee BioMed Central Ltd. 2010
- Received: 29 September 2009
- Accepted: 15 January 2010
- Published: 15 January 2010
Human pathogenic coronavirus NL63 (hCoV-NL63) is a group 1 (alpha) coronavirus commonly associated with respiratory tract infections. In addition to known non-structural and structural proteins all coronaviruses have one or more accessory proteins whose functions are mostly unknown. Our study focuses on hCoV-NL63 open reading frame 3 (ORF 3) which is a highly conserved accessory protein among coronaviruses.
In-silico analysis of the 225 amino acid sequence of hCoV-NL63 ORF 3 predicted a triple membrane-spanning protein. Expression in infected CaCo-2 and LLC-MK2 cells was confirmed by immunofluorescence and Western blot analysis. The protein was detected within the endoplasmatic reticulum/Golgi intermediate compartment (ERGIC) where coronavirus assembly and budding takes place. Subcellular localization studies using recombinant ORF 3 protein transfected in Huh-7 cells revealed occurrence in ERGIC, Golgi- and lysosomal compartments. By fluorescence microscopy of differently tagged envelope (E), membrane (M) and nucleocapsid (N) proteins it was shown that ORF 3 protein colocalizes extensively with E and M within the ERGIC. Using N-terminally FLAG-tagged ORF 3 protein and an antiserum specific to the C-terminus we verified the proposed topology of an extracellular N-terminus and a cytosolic C-terminus. By in-vitro translation analysis and subsequent endoglycosidase H digestion we showed that ORF 3 protein is N-glycosylated at the N-terminus. Analysis of purified viral particles revealed that ORF 3 protein is incorporated into virions and is therefore an additional structural protein.
This study is the first extensive expression analysis of a group 1 hCoV-ORF 3 protein. We give evidence that ORF 3 protein is a structural N-glycosylated and virion-incorporated protein.
- Porcine Epidemic Diarrhea Virus
- Keyhole Limpet Hemocyanin
- Transmissible Gastroenteritis Virus
- Lower Respiratory Tract Disease
- Sucrose Gradient Ultracentrifugation
The human Coronavirus (hCoV)-NL63 constitutes one of four circulating prototypic human Coronaviruses (CoV) . HCoV-NL63 infection causes upper and lower respiratory tract disease and is globally widespread, particularly among children under the age of six years [2–4]. It was shown to be associated with croup [5, 6].
CoV belong to the Nidovirales. The CoV genome consists of a 27 to 33 kb positive single-stranded RNA which is 5'-capped and 3'-polyadenylated . The genome of hCoV-NL63 comprises 27,553 nt and has a gene organization conserved in all CoV, i.e., gene 1a/b, spike (S), open reading frame 3 (ORF 3), envelope (E), membrane (M) and the nucleocapsid (N) gene. CoV virions consist of a nucleocapsid core surrounded by an envelope containing three membrane proteins, S, E, and M. CoV assemble and bud at membranes of the endoplasmic reticulum (ER)-Golgi intermediate compartment (ERGIC) [8, 9]. While the budding site of several CoV has been localized at the ERGIC, the viral surface proteins can also be found in downstream compartments of the secretory pathway . M localizes predominantly in the Golgi apparatus [10, 11], S is found along the secretory pathway and at the plasma membrane [12, 13], and E is detected in perinuclear regions, the ER and Golgi [14–16]. S and M are typically glycosylated and it was shown that glycosylation plays an important role in the generation of bioactive protein conformations and influences fusion activity, receptor binding, and antigenic properties of CoV [17–20].
In addition to the S, E, M and N protein genes, the structural gene portion of CoV genomes contains a variable number of accessory ORFs. Because these accessory ORFs are not shared between different CoV groups, they are also referred to as group-specific ORFs . Proteins encoded by group-specific ORFs of different CoV have been shown to influence pathogenesis, virus replication, or host immune response [21–27]. Others may be dispensable for virus replication in cultured cells of primate or rodent origin, as well as in rodent models [26, 28, 29].
The ORF 3 is the only accessory ORF conserved in all CoVs . Most investigations of its functionality have been done on the example of SARS-CoV ORF 3a. The SARS-CoV ORF 3a protein is expressed in infected cells and patient sera contained antibodies reactive with recombinant ORF 3a antigen. The N-terminal ectodomain was able to induce virus-neutralizing antibodies in rabbits . SARS-CoV ORF 3a protein is a triple-spanning membrane protein with a similar topology as the M protein, and is integrated into virions . Moreover, truncated forms were discovered for recombinantly and virally expressed ORF 3a protein which could also be detected in virions . Unlike the M protein it is not N-glycosylated but O-glycosylated and it was shown to interact with E, M and S protein [16, 34–36]. Subcellular localization of ORF 3a protein was found to be at the Golgi complex and the plasma membrane where it was also internalized by endocytosis . ORF 3a protein was shown to induce apoptosis  and cell cycle arrest  and to up-regulate expression of fibrinogen in lung epithelial cells . Although small interfering RNAs targeting the ORF 3a-specific viral subgenomic RNA were able to reduce viral replication , deletion of ORF 3a from an infectious cDNA clone had no effect on viral replication in cell culture and mice . Moreover it has been demonstrated that SARS-ORF 3a protein forms a homotetramer through inter-protein disulfide bonds, functionally working as a potassium ion channel that modulates virus release . Very recently it was shown that the ORF 3a protein disrupts the architecture of the Golgi apparatus and might thus be responsible for the formation of vesicular structures in which virus replication takes place .
SARS-CoV as a member of CoV group 2b (beta) is only distantly related to the human CoV-NL63, a member of group 1b (alpha). For the ORF 3 protein of group 1 (alpha) CoVs investigations have focused on the porcine epidemic diarrhea virus (PEDV, group 1b, alpha) and transmissible gastroenteritis virus (TGEV, group 1a, alpha) that cause enteropathogenic diarrhea in swine . It was shown that virulence of these viruses could be reduced by altering the ORF 3 gene through cell culture adaptation [44, 45]. For hCoV-NL63, preliminary experiments suggested that deletion of ORF 3 had little influence on viral replication in cell culture . However, the closely related hCoV-229E has a homologous gene named ORF 4 that is split into two ORFs (4a and 4b) in cell culture but maintained in all circulating viruses. This suggests an in-vivo function that may not be necessary for viral replication in cell culture .
In the present study we characterized the ORF 3 protein of hCoV-NL63. We analyzed the expression and subcellular localization of the ORF 3 protein in virus-infected cells and cells transfected transiently with ORF 3 protein-expressing plasmids. We determined the topology of the ORF 3 protein, characterized its glycosylation, and showed that the ORF 3 protein is a structural protein incorporated into viral particles.
Comparison of viral proteins ORF 3 and M of hCoV-NL63 and SARS-CoVa
hCoV-NL63 ORF 3
SARS-CoV ORF 3a
No. amino acids [size in kDa]
No. transmembrane domains (position)
3 (39-61, 70-92, 97-116)
3 (34-56, 77-99,103-125)
4 (20-38, 43-65, 75-97, 129-151)
3 (15-37, 50-72, 77-99)
No. cysteine residues (position)
4 (72, 131, 137, 182)
8 (81, 117, 121, 127, 130, 133, 148, 157)
4 (54, 67, 90, 180)
3 (158, 63, 85)
No. putative N-glycosylation sites (position)
3 (16, 119, 126)
3 (3, 19, 188)
No. putative O-glycosylation sites (position)
3 (28c, 32c, 267-271)
Expression and subcellular localization of ORF 3 protein in virus-infected cells
Subcellular localization of transfected ORF 3 protein in human hepatocellular carcinoma cells (Huh-7) cells
Colocalization of hCoV-NL63 ORF 3 protein with structural proteins
To rule out altered subcellular localization contributed by the fusion tags on the overexpressed structural proteins, experiments were repeated using FLAG-ORF 3 protein in combination with HA tagged E, M and N proteins in HEK-293T cells (Figure 4B). Again, colocalization of ORF 3 protein with E and M protein and, to a far lesser extent, with N protein was seen.
Posttranslational modification of ORF 3 protein
Topology of ORF 3 protein
N-glycosylation of in-vitro translated ORF 3
NL63-ORF 3 protein is a structural viral protein
The ORF 3 protein and its homologues are conserved among CoVs . Although identities on nt and aa level are low, most are predicted to be triple membrane-spanning proteins . While it has been suggested that ORF 3 homologues are dispensable for replication in cell culture, mutations of ORF 3 homologues in transmissible gastroenteritis virus (TGEV) and porcine epidemic diarrhea virus (PEDV) lead to attenuation of virus in-vivo in pig models [44, 51, 52]. Because the SARS-ORF 3a protein underwent positive selective pressure during the human epidemic in 2002/2003 , an important function in-vivo can be assumed for the SARS-CoV ORF 3a protein as well.
Unfortunately, it remains difficult to characterize in-vivo functions of hCoV-NL63 ORF 3 protein due to lack of any animal model. However, it is interesting to note that across all strains of hCoV-NL63 characterized so far, there are no mutations in the ORF 3 amino acid sequence [46, 54]. Conservation of ORF 3 matches results by Donaldson et al., showing that virus production in human airway epithelium was reduced when the ORF 3 protein was replaced by GFP [28, 46]. It has thus been suggested that protein ORF 3 might serve functions involved in viral egress which are relevant for spreading in airway epithelium but not in simpler cell culture .
Results from this study, in particular the subcellular localization of ORF 3 protein along the secretory pathway (ERGIC, Golgi, plasma membrane), the colocalization of NL63-ORF 3 protein with other structural proteins in the ERGIC and the inclusion of the ORF 3 protein in virions give support for a hypothetical function within the viral assembly and budding process. A range of further hypotheses can be derived from earlier investigations into protein ORF 3 functions. These include antigen decoy functions as suggested for SARS-CoV ORF 3a , interference with the regulation of expression of NFκB-dependent cytokines [56, 57] and fibrinogen , and finally the modulation of S protein mediated endocytosis  or an hypothesized down-regulation of the expression of S protein on the cell surface .
Cell culture and materials
Rhesus monkey kidney LLC-MK2 cells (ATCC: CCL-7), human embryonic kidney HEK-293T cells (ATTC: CRL-1573), human hepatocellular carcinoma cell line (Huh-7, JCRB0403 kindly provided by Antoine A. F. de Vries, LUMC, Leiden) and colon carcinoma CaCo-2 cells (ATCC: HTB-37) were grown at 37°C and 5% CO2 in Dulbecco's Modified Eagles Medium (DMEM; Gibco, Karlsruhe, Germany) containing 10% fetal calf serum, 2 mM L-glutamine and 25 U of penicillin/ml and 25 U streptomycin/ml (PAA Laboratories, Linz, Austria). All cells were tested negative for mycoplasms by PCR as described elsewhere . If not stated otherwise materials were provided from Roth, Karlsruhe, Germany.
Virus infections with hCoV-NL63 and plaque assay
For virus stock production either CaCo-2 or LLC-MK2 cells were inoculated with hCoV-NL63 (8th passage Amsterdam strain I; accession no. NC_005831) at a multiplicity of infection (MOI) of 0.01 and infected cells were cultured at 37°C and 5% CO2 for five to seven days before harvesting. After centrifugation at 6,000 × g for 10 min supernatant was aliquoted and stored at -80°C. Titers were determined by plaque assay performed as described elsewhere . Briefly, after incubation of the plaque assays at 37°C and 5% CO2 for four days cells were fixed with 4% formaldehyde, stained with crystal violet solution and results were interpreted as described previously .
Construction of plasmids
Oligonucleotidesa used for cloning procedures
Sequence (5'-end to 3'-end)
45 - 63
GCAGCAGAATTC ATGGACTACAAGGACGACGATGACAAG CCTTTTGGTGGCCTATTTCAACTTAC
GCAGCAGAATTC ATGTACCCATACGATGTTCCAGATTACGCT TTCCTTCGATTAATTGATGACAATG
GCAGCAGAATTC ATGTACCCATACGATGTTCCAGATTACGCT TCTAATAGTAGTGTGCCTCTTTTAGAG
GCAGCAGAATTC ATGTACCCATACGATGTTCCAGATTACGCT GCTAGTGTAAATTGGGCCGATGACAG
For PCR amplification of FLAG-ORF 3 as well as HA tagged E, M and N and subsequent cloning into a pCAGGS vector (kindly provided by Prof. Dr. Stephan Becker, University of Marburg) we used 5'Eco-FLAG_O3-63 and 3'Not-O3-63, 5'Eco-HA-E and 3'Not-E, 5'Eco-HA-M and 3'Not-M, 5'Eco-HA-N and 3'Not-N, respectively (Table 2). In this case PCR products were digested with restriction endonucleases EcoRI and NotI (Fermentas) before cloning into the pCAGGS vector (also digested and additionally dephosphorylated before use).
Generally, PCR was performed with Platinum®Taq DNA Polymerase High Fidelity (Invitrogen, Karlsruhe, Germany), and conditions were as follows: 94°C for 2 min, followed by 35 cycles of 94°C for 30 s, primer specific temperature for 30 s, and 72°C for 90 s, with a final extension at 72°C for 10 min. The different genes were cloned into pcDNA3.1/V5-His-TOPO (eukaryotic expression and in-vitro translation) and pcDNA3.1/NT-GFP-TOPO (eukaryotic expression) with the help of TOPO Expression Kits (Invitrogen) according to the manufacturer's instructions. Cloning of FLAG-tagged ORF 3 into the pCAGGS vector was done conventionally with T4 ligase (Invitrogen) according to suppliers' description. Correct cloning was confirmed by sequencing (Abi Prism 3,100; Applied Biosystems, Foster City, USA).
Generation of polyclonal ORF 3 antiserum
The generation of a polyclonal antiserum against ORF 3 was done with the help of keyhole limpet hemocyanin (KLH) coupled peptides. Two peptides were synthesized corresponding to aa positions 182-197 and 211-225 (Eurogentec, Seraing, Belgium). Immunization was performed in-house. Briefly, a chinchilla rabbit was immunized four times with 200 μg of a mixture of the two KLH coupled peptides and sera were tested as suggested by the manufacturer by enzyme-linked immunosorbent assay (ELISA) using the corresponding uncoupled peptides. We then tested serum with IFA using infected LLC-MK2 cells (Figure 2) as well as with prokaryotic recombinant proteins with the help of Dot blot and Western blot analysis (data not shown). The bleeding for the applied anti-ORF 3 serum was carried out 20 days after the fourth injection and sera were used directly.
Expression analysis and subcellular localization studies of native viral proteins by indirect IFA and Western blot
Typically, 8 × 104 CaCo-2 or LLC-MK2 cells were seeded on glass slides in a 24-well plate and infected with hCoV-NL63 as described above. Two to four days after infection the cells were fixed with paraformaldehyde (4%) for 15 min and permeabilized with 0.1% TritonX100 (Merck, Darmstadt, Germany) for 10 min. Afterwards the cells were washed with PBS again and then incubated with the primary antibody, diluted 1:100 in sample buffer (EUROIMMUN, Lübeck, Germany), at 37°C for 1 h. The ERGIC was stained with the help of mouse-anti-ERGIC53 (Axxora, Grünberg, Germany). In order to stain the Golgi apparatus we used a mouse-anti-Golgi 58 K (Sigma-Aldrich, Munich, Germany). For staining of the trans-Golgi Network and lysosomal compartment we applied a goat-anti-LAMP-1 antibody (Santa Cruz Biotechnology, Heidelberg, Germany). Secondary detection was done with fluorescein isothiocyanate (FITC) or cyanine 2 (Cy2)-conjugated goat-anti-rabbit as well as with rhodamine or Cy3-conjugated goat-anti-mouse or donkey-anti-goat antibody (Dianova, Hamburg, Germany) at 37°C in a wet chamber for 30 min. Slides were mounted and analyzed by cLSM 510 META laser confocal microscope (Zeiss, Jena, Germany).
Western blot analysis of viral proteins was done as described elsewhere . For titration of the different rabbit antisera we used hCoV-NL63 cell lysate generated from LLC-MK2 infected cells five to seven dpi (~1 × 107 cells/blot) for Western blotting and incubated the produced nitrocellulose strips with the different rabbit antisera (pre-immune sera as negative control) at dilutions ranging from 1:500 up to 1:256,000 (data not shown). Generally, cells were lysed in RIPA lysis buffer (150 mM NaCl, 1% Igepal CA-630, 0.5% sodium deoxycholat, 0.1% SDS, 50 mM Tris (pH 8.0)) and separated on a 12% SDS-PAGE gel. Western blotting was performed by using anti-ORF 3, anti-M, anti-N at dilutions 1:4,000, 1:250,000 and 1:24,000 respectively. Secondary detection was done with the help of SuperSignal® West Dura Extended or Femto Chemiluminescence Substrate (Pierce Biotechnology, Rockford, USA).
Transient transfection of recombinant proteins for colocalization studies by indirect IFA and Western blot analysis
Transfections of HEK-293T and Huh-7 cells with eukaryotic expression vectors containing the fusion genes GFP-E, GFP-M, GFP-N, HA-E, HA-M, HA-N and FLAG-ORF 3 were performed with the help of FuGENE HD (Roche, Basel, Switzerland) transfection reagent as described above using 24-well plates provided with glass slides. After a 24 h incubation at 37°C and 5% CO2transfected cells were washed with PBS and fixed with paraformaldehyde (4%), permeabilized with TritonX100 and incubated with rabbit-anti-FLAG (Sigma) and mouse-anti-ERGIC53 (Axxora) primary antibodies, both diluted 1:100 with sample buffer (EUROIMMUN). Secondary detection was performed with Cy3-conjugated goat-anti-rabbit (1:200) and Cy5 labelled goat-anti-mouse (1:100) antibodies (Dianova). Slides were mounted and analyzed by confocal laser scanning microscopy. For Western blot analysis of recombinant ORF 3 proteins (FLAG-ORF 3, rORF 3) transfections were performed in 6-well plates using FuGENE HD transfection reagent. Transfection was performed with 6 μg DNA and 12 μl FuGENE HD in 100 μl DMEM. Transfected cells were washed three times with ice cold PBS and harvested for Western blot analysis after incubation for 26 to 48 h at 37°C and 5% CO2. Cell lysis was performed with RIPA lysis buffer (~4 × 107 cells/ml) containing Protease Inhibitor Cocktail III (Calbiochem, San Diego, USA) and Benzonase (25 U/ml) (Novagen, Madison, USA). After 30 min incubation on ice samples were sonicated twice for 30 s (Branson Sonifier 450, Branson, Danbury, USA) and centrifuged at 13,000 × g for 1 min at 4°C. For detection of the different proteins we used rabbit-anti-FLAG (Sigma, diluted 1:5,000) or anti-ORF 3 antiserum (1:3000) and incubated blots for 1 to 2 h at room temperature. As secondary antibody we applied a goat-anti-mouse or rabbit horseradish peroxidase (HRP)-conjugated antibody (Pierce Biotechnology) for 1 h at room temperature. Detection was performed by using SuperSignal® West Femto Chemiluminescence Substrate (Pierce Biotechnology).
In-vitro translation of ORF 3 and analysis of glycosylation by endoglycosidase H digestion
Plasmids pcDNA3.1-ORF 3-V5/His, pcDNA3.1-ORF 3-N16Q-V5/His and pcDNA3.1-ORF 3 were employed in the TNT T7 quick coupled reticulocyte lysate system (Promega, Mannheim, Germany) according to the manufacturer's description. The proteins were metabolically labelled with [35S]methionine (GE Healthcare, Munich, Germany) and translated in the presence of canine pancreatic microsomal membranes (Promega). Membrane-bound proteins were pelleted at 13,000 × g for 15 min and resuspended in PBS. Samples were split in half and incubated for 1 h at 37°C with endoglycosidase H (Endo H; New England Biolabs, Frankfurt, Germany) or, as control, without additives. Afterwards samples were subjected to SDS-PAGE. Radioactive signals were visualized by exposing dried gels to BioImage plates, which were scanned by using a bioimager analyzer (BAS-1,000; Fuji).
Purification of viral particles by sucrose gradient ultracentrifugation
Purification of viral particles was performed by sucrose gradient ultracentrifugation as described elsewhere . Briefly, 45 ml viral supernatant from infected CaCo-2 cells was cleared from cell debris 4 dpi and subsequently applied onto two discontinuous and one continuous sucrose cushion of 20% to 60%. The continuous cushion was divided into ten fractions and viral particles were pelleted by ultracentrifugation through a 20% sucrose cushion. Virus pellets were resuspended in 100 μL PBS and stored at -80°C.
Prediction of protein topology and subcellular localization was done by NetNGlyc, NetOGlyc, TMHMM http://www.cbs.dtu.dk/services/, TMPred http://www.ch.embnet.org/software/TMPRED_form.html, and ProDiV/TOPCONS http://topcons.cbr.su.se/index.php. The alignments and a sequence identity matrix were done by using BLAST and MEGA4 (BLOSUM; parameters p-distance and pair wise deletion).
This study was supported by the German Ministry of Education and Research (Project Code "Ökologie und Pathogenese von SARS"), and the European Commission (FP7 framework program No 223498 EMPERIE). We are grateful to A. Teichmann for excellent technical assistance. For providing us with Huh-7 cells we thank A. A. F. de Vries, LUMC, Leiden, The Netherlands. Special thanks to Dr. H.G. Bae, Dr. K. Madela, R. Kallies for helping with the confocal laser scanning microscopy and Dr. J. F. Drexler as well as Dr. B. Hartlieb for giving technical advice.
- Hoek L, Pyrc K, Jebbink MF, Vermeulen-Oost W, Berkhout RJ, Wolthers KC, Wertheim-van Dillen PM, Kaandorp J, Spaargaren J, Berkhout B: Identification of a new human coronavirus. Nat Med 2004, 10: 368-373. 10.1038/nm1024PubMedView ArticleGoogle Scholar
- Hofmann H, Pyrc K, Hoek L, Geier M, Berkhout B, Pohlmann S: Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci USA 2005, 102: 7988-7993. 10.1073/pnas.0409465102PubMedPubMed CentralView ArticleGoogle Scholar
- Han TH, Chung JY, Kim SW, Hwang ES: Human Coronavirus-NL63 infections in Korean children, 2004-2006. J Clin Virol 2007, 38: 27-31. 10.1016/j.jcv.2006.10.009PubMedView ArticleGoogle Scholar
- Vabret A, Mourez T, Dina J, Hoek L, Gouarin S, Petitjean J, Brouard J, Freymuth F: Human coronavirus NL63, France. Emerg Infect Dis 2005, 11: 1225-1229.PubMedPubMed CentralView ArticleGoogle Scholar
- Pyrc K, Berkhout B, Hoek L: The novel human coronaviruses NL63 and HKU1. J Virol 2007, 81: 3051-3057. 10.1128/JVI.01466-06PubMedPubMed CentralView ArticleGoogle Scholar
- Hoek L, Sure K, Ihorst G, Stang A, Pyrc K, Jebbink MF, Petersen G, Forster J, Berkhout B, Uberla K: Croup is associated with the novel coronavirus NL63. PLoS Med 2005, 2: e240. 10.1371/journal.pmed.0020240PubMedPubMed CentralView ArticleGoogle Scholar
- Masters PS: The molecular biology of coronaviruses. Adv Virus Res 2006, 66: 193-292. 10.1016/S0065-3527(06)66005-3PubMedView ArticleGoogle Scholar
- Klumperman J, Locker JK, Meijer A, Horzinek MC, Geuze HJ, Rottier PJ: Coronavirus M proteins accumulate in the Golgi complex beyond the site of virion budding. J Virol 1994, 68: 6523-6534.PubMedPubMed CentralGoogle Scholar
- Tooze J, Tooze S, Warren G: Replication of coronavirus MHV-A59 in sac- cells: determination of the first site of budding of progeny virions. Eur J Cell Biol 1984, 33: 281-293.PubMedGoogle Scholar
- Escors D, Ortego J, Laude H, Enjuanes L: The membrane M protein carboxy terminus binds to transmissible gastroenteritis coronavirus core and contributes to core stability. J Virol 2001, 75: 1312-1324. 10.1128/JVI.75.3.1312-1324.2001PubMedPubMed CentralView ArticleGoogle Scholar
- Locker JK, Opstelten DJ, Ericsson M, Horzinek MC, Rottier PJ: Oligomerization of a trans-Golgi/trans-Golgi network retained protein occurs in the Golgi complex and may be part of its retention. J Biol Chem 1995, 270: 8815-8821. 10.1074/jbc.270.15.8815PubMedView ArticleGoogle Scholar
- Lontok E, Corse E, Machamer CE: Intracellular targeting signals contribute to localization of coronavirus spike proteins near the virus assembly site. J Virol 2004, 78: 5913-5922. 10.1128/JVI.78.11.5913-5922.2004PubMedPubMed CentralView ArticleGoogle Scholar
- Opstelten DJ, Raamsman MJ, Wolfs K, Horzinek MC, Rottier PJ: Coexpression and association of the spike protein and the membrane protein of mouse hepatitis virus. Adv Exp Med Biol 1995, 380: 291-297.PubMedView ArticleGoogle Scholar
- Corse E, Machamer CE: The cytoplasmic tails of infectious bronchitis virus E and M proteins mediate their interaction. Virology 2003, 312: 25-34. 10.1016/S0042-6822(03)00175-2PubMedView ArticleGoogle Scholar
- Raamsman MJ, Locker JK, de Hooge A, de Vries AA, Griffiths G, Vennema H, Rottier PJ: Characterization of the coronavirus mouse hepatitis virus strain A59 small membrane protein E. J Virol 2000, 74: 2333-2342. 10.1128/JVI.74.5.2333-2342.2000PubMedPubMed CentralView ArticleGoogle Scholar
- Nal B, Chan C, Kien F, Siu L, Tse J, Chu K, Kam J, Staropoli I, Crescenzo-Chaigne B, Escriou N, et al.: Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E. J Gen Virol 2005, 86: 1423-1434. 10.1099/vir.0.80671-0PubMedView ArticleGoogle Scholar
- Alexander S, Elder JH: Carbohydrate dramatically influences immune reactivity of antisera to viral glycoprotein antigens. Science 1984, 226: 1328-1330. 10.1126/science.6505693PubMedView ArticleGoogle Scholar
- Braakman I, van Anken E: Folding of viral envelope glycoproteins in the endoplasmic reticulum. Traffic 2000, 1: 533-539. 10.1034/j.1600-0854.2000.010702.xPubMedView ArticleGoogle Scholar
- de Haan CA, de Wit M, Kuo L, Montalto-Morrison C, Haagmans BL, Weiss SR, Masters PS, Rottier PJ: The glycosylation status of the murine hepatitis coronavirus M protein affects the interferogenic capacity of the virus in vitro and its ability to replicate in the liver but not the brain. Virology 2003, 312: 395-406. 10.1016/S0042-6822(03)00235-6PubMedView ArticleGoogle Scholar
- Wissink EH, Kroese MV, Maneschijn-Bonsing JG, Meulenberg JJ, van Rijn PA, Rijsewijk FA, Rottier PJ: Significance of the oligosaccharides of the porcine reproductive and respiratory syndrome virus glycoproteins GP2a and GP5 for infectious virus production. J Gen Virol 2004, 85: 3715-3723. 10.1099/vir.0.80402-0PubMedView ArticleGoogle Scholar
- de Haan CA, Masters PS, Shen X, Weiss S, Rottier PJ: The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host. Virology 2002, 296: 177-189. 10.1006/viro.2002.1412PubMedView ArticleGoogle Scholar
- Ortego J, Sola I, Almazan F, Ceriani JE, Riquelme C, Balasch M, Plana J, Enjuanes L: Transmissible gastroenteritis coronavirus gene 7 is not essential but influences in vivo virus replication and virulence. Virology 2003, 308: 13-22. 10.1016/S0042-6822(02)00096-XPubMedView ArticleGoogle Scholar
- Herrewegh AA, Vennema H, Horzinek MC, Rottier PJ, de Groot RJ: The molecular genetics of feline coronaviruses: comparative sequence analysis of the ORF7a/7b transcription unit of different biotypes. Virology 1995, 212: 622-631. 10.1006/viro.1995.1520PubMedView ArticleGoogle Scholar
- Haijema BJ, Volders H, Rottier PJ: Live, attenuated coronavirus vaccines through the directed deletion of group-specific genes provide protection against feline infectious peritonitis. J Virol 2004, 78: 3863-3871. 10.1128/JVI.78.8.3863-3871.2004PubMedPubMed CentralView ArticleGoogle Scholar
- Snijder EJ, Bredenbeek PJ, Dobbe JC, Thiel V, Ziebuhr J, Poon LL, Guan Y, Rozanov M, Spaan WJ, Gorbalenya AE: Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol 2003, 331: 991-1004. 10.1016/S0022-2836(03)00865-9PubMedView ArticleGoogle Scholar
- Frieman MB, Yount B, Sims AC, Deming DJ, Morrison TE, Sparks J, Denison M, Heise M, Baric RS: SARS coronavirus accessory ORFs encode luxury functions. Adv Exp Med Biol 2006, 581: 149-152. full_textPubMedView ArticleGoogle Scholar
- Pfefferle S, Krahling V, Ditt V, Grywna K, Muhlberger E, Drosten C: Reverse genetic characterization of the natural genomic deletion in SARS-Coronavirus strain Frankfurt-1 open reading frame 7b reveals an attenuating function of the 7b protein in-vitro and in-vivo. Virol J 2009, 6: 131. 10.1186/1743-422X-6-131PubMedPubMed CentralView ArticleGoogle Scholar
- Yount B, Roberts RS, Sims AC, Deming D, Frieman MB, Sparks J, Denison MR, Davis N, Baric RS: Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice. J Virol 2005, 79: 14909-14922. 10.1128/JVI.79.23.14909-14922.2005PubMedPubMed CentralView ArticleGoogle Scholar
- Schaecher SR, Touchette E, Schriewer J, Buller RM, Pekosz A: Severe acute respiratory syndrome coronavirus gene 7 products contribute to virus-induced apoptosis. J Virol 2007, 81: 11054-11068. 10.1128/JVI.01266-07PubMedPubMed CentralView ArticleGoogle Scholar
- Tang XC, Zhang JX, Zhang SY, Wang P, Fan XH, Li LF, Li G, Dong BQ, Liu W, Cheung CL, et al.: Prevalence and genetic diversity of coronaviruses in bats from China. J Virol 2006, 80: 7481-7490. 10.1128/JVI.00697-06PubMedPubMed CentralView ArticleGoogle Scholar
- Akerstrom S, Tan YJ, Mirazimi A: Amino acids 15-28 in the ectodomain of SARS coronavirus 3a protein induces neutralizing antibodies. FEBS Lett 2006, 580: 3799-3803. 10.1016/j.febslet.2006.06.002PubMedView ArticleGoogle Scholar
- Ito N, Mossel EC, Narayanan K, Popov VL, Huang C, Inoue T, Peters CJ, Makino S: Severe acute respiratory syndrome coronavirus 3a protein is a viral structural protein. J Virol 2005, 79: 3182-3186. 10.1128/JVI.79.5.3182-3186.2005PubMedPubMed CentralView ArticleGoogle Scholar
- Shen S, Lin PS, Chao YC, Zhang A, Yang X, Lim SG, Hong W, Tan YJ: The severe acute respiratory syndrome coronavirus 3a is a novel structural protein. Biochem Biophys Res Commun 2005, 330: 286-292. 10.1016/j.bbrc.2005.02.153PubMedView ArticleGoogle Scholar
- Voss D, Kern A, Traggiai E, Eickmann M, Stadler K, Lanzavecchia A, Becker S: Characterization of severe acute respiratory syndrome coronavirus membrane protein. FEBS Lett 2006, 580: 968-973. 10.1016/j.febslet.2006.01.026PubMedView ArticleGoogle Scholar
- Oostra M, de Haan CA, de Groot RJ, Rottier PJ: Glycosylation of the severe acute respiratory syndrome coronavirus triple-spanning membrane proteins 3a and M. J Virol 2006, 80: 2326-2336. 10.1128/JVI.80.5.2326-2336.2006PubMedPubMed CentralView ArticleGoogle Scholar
- Tan YJ, Teng E, Shen S, Tan TH, Goh PY, Fielding BC, Ooi EE, Tan HC, Lim SG, Hong W: A novel severe acute respiratory syndrome coronavirus protein, U274, is transported to the cell surface and undergoes endocytosis. J Virol 2004, 78: 6723-6734. 10.1128/JVI.78.13.6723-6734.2004PubMedPubMed CentralView ArticleGoogle Scholar
- Law PT, Wong CH, Au TC, Chuck CP, Kong SK, Chan PK, To KF, Lo AW, Chan JY, Suen YK, et al.: The 3a protein of severe acute respiratory syndrome-associated coronavirus induces apoptosis in Vero E6 cells. J Gen Virol 2005, 86: 1921-1930. 10.1099/vir.0.80813-0PubMedView ArticleGoogle Scholar
- Yuan X, Yao Z, Wu J, Zhou Y, Shan Y, Dong B, Zhao Z, Hua P, Chen J, Cong Y: G1 phase cell cycle arrest induced by SARS-CoV 3a protein via the cyclin D3/pRb pathway. Am J Respir Cell Mol Biol 2007, 37: 9-19. 10.1165/rcmb.2005-0345RCPubMedView ArticleGoogle Scholar
- Tan YJ, Tham PY, Chan DZ, Chou CF, Shen S, Fielding BC, Tan TH, Lim SG, Hong W: The severe acute respiratory syndrome coronavirus 3a protein up-regulates expression of fibrinogen in lung epithelial cells. J Virol 2005, 79: 10083-10087. 10.1128/JVI.79.15.10083-10087.2005PubMedPubMed CentralView ArticleGoogle Scholar
- Akerstrom S, Mirazimi A, Tan YJ: Inhibition of SARS-CoV replication cycle by small interference RNAs silencing specific SARS proteins, 7a/7b, 3a/3b and S. Antiviral Res 2007, 73: 219-227. 10.1016/j.antiviral.2006.10.008PubMedView ArticleGoogle Scholar
- Lu W, Zheng BJ, Xu K, Schwarz W, Du L, Wong CK, Chen J, Duan S, Deubel V, Sun B: Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus release. Proc Natl Acad Sci USA 2006, 103: 12540-12545. 10.1073/pnas.0605402103PubMedPubMed CentralView ArticleGoogle Scholar
- Freundt EC, Yu L, Goldsmith CS, Welsh S, Cheng A, Yount B, Liu W, Frieman MB, Buchholz UJ, Screaton GR, et al.: The ORF 3a Protein of SARS-CoV Promotes Membrane Rearrangement and Cell Death. J Virol 2009.Google Scholar
- Andries K, Pensaert M: Vomiting and wasting disease, a coronavirus infection of pigs. Adv Exp Med Biol 1981, 142: 399-408.PubMedView ArticleGoogle Scholar
- Song DS, Yang JS, Oh JS, Han JH, Park BK: Differentiation of a Vero cell adapted porcine epidemic diarrhea virus from Korean field strains by restriction fragment length polymorphism analysis of ORF 3. Vaccine 2003, 21: 1833-1842. 10.1016/S0264-410X(03)00027-6PubMedView ArticleGoogle Scholar
- Woods RD: Efficacy of a transmissible gastroenteritis coronavirus with an altered ORF-3 gene. Can J Vet Res 2001, 65: 28-32.PubMedPubMed CentralGoogle Scholar
- Donaldson EF, Yount B, Sims AC, Burkett S, Pickles RJ, Baric RS: Systematic assembly of a full-length infectious clone of human coronavirus NL63. J Virol 2008, 82: 11948-11957. 10.1128/JVI.01804-08PubMedPubMed CentralView ArticleGoogle Scholar
- Dijkman R, Jebbink MF, Wilbrink B, Pyrc K, Zaaijer HL, Minor PD, Franklin S, Berkhout B, Thiel V, Hoek L: Human coronavirus 229E encodes a single ORF4 protein between the spike and the envelope genes. Virol J 2006, 3: 106. 10.1186/1743-422X-3-106PubMedPubMed CentralView ArticleGoogle Scholar
- Fielding BC, Suliman T: Comparative analysis of human coronavirus-NL63 ORF3 protein homologues. African Journal of Biotechnology 2009, 8: 3175-3178.Google Scholar
- Yu CJ, Chen YC, Hsiao CH, Kuo TC, Chang SC, Lu CY, Wei WC, Lee CH, Huang LM, Chang MF, et al.: Identification of a novel protein 3a from severe acute respiratory syndrome coronavirus. FEBS Lett 2004, 565: 111-116. 10.1016/j.febslet.2004.03.086PubMedView ArticleGoogle Scholar
- Yuan X, Li J, Shan Y, Yang Z, Zhao Z, Chen B, Yao Z, Dong B, Wang S, Chen J, Cong Y: Subcellular localization and membrane association of SARS-CoV 3a protein. Virus Res 2005, 109: 191-202. 10.1016/j.virusres.2005.01.001PubMedView ArticleGoogle Scholar
- Duarte M, Tobler K, Bridgen A, Rasschaert D, Ackermann M, Laude H: Sequence analysis of the porcine epidemic diarrhea virus genome between the nucleocapsid and spike protein genes reveals a polymorphic ORF. Virology 1994, 198: 466-476. 10.1006/viro.1994.1058PubMedView ArticleGoogle Scholar
- McGoldrick A, Lowings JP, Paton DJ: Characterisation of a recent virulent transmissible gastroenteritis virus from Britain with a deleted ORF 3a. Arch Virol 1999, 144: 763-770. 10.1007/s007050050541PubMedView ArticleGoogle Scholar
- Tang X, Li G, Vasilakis N, Zhang Y, Shi Z, Zhong Y, Wang LF, Zhang S: Differential stepwise evolution of SARS coronavirus functional proteins in different host species. BMC Evol Biol 2009, 9: 52. 10.1186/1471-2148-9-52PubMedPubMed CentralView ArticleGoogle Scholar
- Pyrc K, Dijkman R, Deng L, Jebbink MF, Ross HA, Berkhout B, Hoek L: Mosaic structure of human coronavirus NL63, one thousand years of evolution. J Mol Biol 2006, 364: 964-973. 10.1016/j.jmb.2006.09.074PubMedView ArticleGoogle Scholar
- Huang C, Narayanan K, Ito N, Peters CJ, Makino S: Severe acute respiratory syndrome coronavirus 3a protein is released in membranous structures from 3a protein-expressing cells and infected cells. J Virol 2006, 80: 210-217. 10.1128/JVI.80.1.210-217.2006PubMedPubMed CentralView ArticleGoogle Scholar
- Narayanan K, Huang C, Makino S: SARS coronavirus accessory proteins. Virus Res 2008, 133: 113-121. 10.1016/j.virusres.2007.10.009PubMedPubMed CentralView ArticleGoogle Scholar
- Kanzawa N, Nishigaki K, Hayashi T, Ishii Y, Furukawa S, Niiro A, Yasui F, Kohara M, Morita K, Matsushima K, et al.: Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF-kappaB activation. FEBS Lett 2006, 580: 6807-6812. 10.1016/j.febslet.2006.11.046PubMedView ArticleGoogle Scholar
- Tan YJ, Lim SG, Hong W: Understanding the accessory viral proteins unique to the severe acute respiratory syndrome (SARS) coronavirus. Antiviral Res 2006, 72: 78-88. 10.1016/j.antiviral.2006.05.010PubMedView ArticleGoogle Scholar
- van Kuppeveld FJ, Melchers WJ, Willemse HF, Kissing J, Galama JM, Logt JT: Detection of Mycoplasma pulmonis in experimentally infected laboratory rats by 16S rRNA amplification. J Clin Microbiol 1993, 31: 524-527.PubMedPubMed CentralGoogle Scholar
- Herzog P, Drosten C, Muller MA: Plaque assay for human coronavirus NL63 using human colon carcinoma cells. Virol J 2008, 5: 138. 10.1186/1743-422X-5-138PubMedPubMed CentralView ArticleGoogle Scholar
- Niedrig M, Lademann M, Emmerich P, Lafrenz M: Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA. Trop Med Int Health 1999, 4: 867-871. 10.1046/j.1365-3156.1999.00496.xPubMedView ArticleGoogle Scholar
- Hattermann K, Muller MA, Nitsche A, Wendt S, Donoso Mantke O, Niedrig M: Susceptibility of different eukaryotic cell lines to SARS-coronavirus. Arch Virol 2005, 150: 1023-1031. 10.1007/s00705-004-0461-1PubMedView ArticleGoogle Scholar
- Muller MA, Paweska JT, Leman PA, Drosten C, Grywna K, Kemp A, Braack L, Sonnenberg K, Niedrig M, Swanepoel R: Coronavirus antibodies in African bat species. Emerg Infect Dis 2007, 13: 1367-1370.PubMedPubMed CentralView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.